Two Cases of Hypersexuality Probably Associated with Aripiprazole
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Sexual dysfunction is a common side effect in patients treated with antipsychotics but significant differences exist across different compounds. We report hypersexuality symptoms in two female patients with schizophrenia who were receiving treatment with aripiprazole. The patients experienced more frequent sexual desire and greater sexual preoccupation after taking aripiprazole. We discuss the potential neuro-chemical mechanisms for this and argue that aripiprazole's unique pharmacological profile, partial agonism with high affinity at dopamine D2-receptor, may have contributed to the development of these symptoms.
Abstract
Sexual dysfunction is a common side effect in patients treated with antipsychotics but significant differences exist across different compounds. We report hypersexuality symptoms in two female patients with schizophrenia who were receiving treatment with aripiprazole. The patients experienced more frequent sexual desire and greater sexual preoccupation after taking aripiprazole. We discuss the potential neuro-chemical mechanisms for this and argue that aripiprazole's unique pharmacological profile, partial agonism with high affinity at dopamine D2-receptor, may have contributed to the development of these symptoms.
참고문헌 (17)
- Serretti A, "A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics", Int Clin Psychopharmacol, 26, pp.130~140 (2011)
- Cutler AJ, "Sexual dysfunction and antipsychotic treatment", Psychoneuroendocrinology, 28(Suppl 1), pp.69~82 (2003)
- Haddad PM, "Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management", Drugs, 64, pp.2291~2314 (2004)
- Knegtering H, "What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning", Psychoneuroendocrinology, 28(Suppl 2), pp.109~123 (2003)
- Menon A, "Increased libido associated with quetiapine", J Psychopharmacol, 20, pp.125~127 (2006)
- Schlachetzki JC, "Aripiprazole induced hypersexuality in a 24-year-old female patient with schizoaffective disorder", J Clin Psychopharmacol, 28, pp.567~568 (2008)
- Kerwin R, "A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study", Eur Psychiatry, 22, pp.433~443 (2007)
- Sansone RA, "Pramipexole and compulsive masturbation", Psychiatry (Edgmont), 4, pp.57~59 (2007)
- Pfaus JG, "Pathways of sexual desire", J Sex Med, 6, pp.1506~1533 (2009)
- Kessler RM, "Aripiprazole: what is the role of dopamine D(2) receptor partial agonism", Am J Psychiatry, 164, pp.1310~1312 (2007)
- Stahl SM, "Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, “Goldilocks” actions at dopamine receptors", J Clin Psychiatry, 62, pp.841~842 (2001)
- Hoyer D, "Partial agonists, full agonists, antagonists: dilemmas of definition", Trends Pharmacol Sci, 14, pp.270~275 (1993)
- Koener B, "Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole", Am J Psychiatry, 164, pp.1437~1438 (2007)
- Grunder G, "Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia", Pharmacopsychiatry, 39(Suppl 1), pp.S21~S25 (2006)
- Meston CM, "The neurobiology of sexual function", Arch Gen Psychiatry, 57, pp.1012~1030 (2000)
- Farah A, "Relief of SSRI-induced sexual dysfunction with mirtazapine treatment", J Clin Psychiatry, 60, pp.260~261 (1999)
- Dossenbach M, "Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation", Int J Neuropsychopharmacol, 8, pp.195~201 (2005)